Montessuit, Christophe <br/><br/>
Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.  [electronic resource] 

 -  Endocrinology  Mar 2008 
 - 1064-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/en.2007-0656  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinase Kinases<br/>Alitretinoin<br/>Animals<br/>Cells, Cultured<br/>Cytoskeleton--drug effects<br/>Glucose--metabolism<br/>Glucose Transporter Type 4--metabolism<br/>Insulin--physiology<br/>Insulin Resistance--physiology<br/>Male<br/>Microtubules--drug effects<br/>Myocytes, Cardiac--drug effects<br/>PPAR gamma--agonists<br/>Phenoxyacetates--pharmacology<br/>Protein Kinases--pharmacology<br/>Pyrimidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Retinoid X Receptors--agonists<br/>Signal Transduction--drug effects<br/>Thiazolidinediones--pharmacology<br/>Tretinoin--pharmacology